LDLR and breast cancer: The study of clinical breast tissues exhibited an increased cholesterol level and elevated expressions of few cholesterol regulatory genes (e.g., HMGCoR, LDLR and SREBP1) in malignant breast tumor tissues as compared to benign breast tissues (Fig 1).